Comprehensive comparison of Pacific Biosciences and Oxford Nanopore Technologies and their applications to transcriptome analysisJason L. Weirather, Kin Fai Au|F1000Research|2017Cited by 514
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell CarcinomaJonathan D. Schoenfeld, Robert I. Haddad, Glenn J. Hanna et al.|JAMA Oncology|2020Cited by 350
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung CancerBiagio Ricciuti, Mark M. Awad, Giuseppe Lamberti et al.|Journal of Clinical Oncology|2024Cited by 124
Comprehensive comparison of Pacific Biosciences and Oxford Nanopore Technologies and their applications to transcriptome analysisJason L. Weirather, Kin Fai Au|F1000Research|2017Cited by 83
MAPS: pathologist-level cell type annotation from tissue images through machine learningMuhammad Shaban, Faisal Mahmood, Yunhao Bai et al.|Nature Communications|2024Cited by 49